Aberrant expression of USP14 is associated with progression of various cancers, including colorectal carcinoma 26, hepatocellular carcinoma 44, pancreatic ductal adenocarcinoma 27, breast cancer 45, and gastric cancer 46. This evidence concerns the gene USP14 and hepatocellular carcinoma.